Superworth

Precigen profit margin PGEN

Gross, operating and net profit as a share of revenue over the last twelve months, from 2014.

Net margin, 12 months
n/m
a quarter missing
Peer median
11.1%

Precigen's net margin over the last twelve months can't be worked out yet: a quarter of its results is missing from our data.

Profit margin over time

GrossOperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating marginGross margin
FY2025n/an/an/a
FY2024n/an/an/a
FY2023n/an/an/a
FY2022n/an/an/a
FY2021n/an/an/a
FY2020n/an/an/a
FY2019n/an/an/a
FY2018n/an/a60.6%
FY2017−50.6%−59.6%72.7%
FY2016−97.7%−65.6%67.7%
FY2015−48.7%−84.6%63.2%
FY2014n/a−97.3%73.2%
FY2013n/an/an/a
FY2012n/an/an/a

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a year
Q2 FY26n/an/a
Q1 FY26n/an/a
Q4 FY25n/an/a
Q3 FY25n/an/a
Q2 FY25n/an/a
Q1 FY25n/an/a
Q4 FY24n/an/a
Q3 FY24n/an/a
Q2 FY24n/an/a
Q1 FY24n/an/a
Q4 FY23n/an/a
Q3 FY23n/an/a

Against its peers

Companies in Drug Manufacturers - General nearest Precigen's size, closest first, today.

CompanyProfit margin
PGENPrecigenn/m
PBHPrestige Consumer Healthcare15.6%
HRMYHarmony Biosciences18.9%
NRIXNurix Therapeutics42.0%
ANIPANI Pharmaceuticals11.1%
PAHCPhibro Animal Health6.6%
ANABAnaptysbion/m
PCRXPacira BioSciences2.0%
OGNOrganon3.4%
LQDALiquidia30.7%
ARQTArcutis Biotherapeutics6.1%
Peer median11.1%

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Precigen

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.